abstract |
This invention relates to pharmaceutical combinations of a prostaglandinnagonist and a HMG-CoA reductase inhibitor, methods of using such combinationsnand kits containing such combinations. The pharmaceutical combinations,nmethods and kits are useful to enhance bone formation in mammals, includingnhumans. |